相关实验视频

Updated: Jun 21, 2025

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Software-Assisted Quantitative Measurement of Osteoarthritic Subchondral Bone Thickness

Published on: March 18, 2022

针对与衰老相关的基因MAPK12和FOS,以缓解骨关节炎

Nana Geng¹, Menglin Xian¹, Lin Deng¹

¹State Key Laboratory of Ultrasound in Medicine and Engineering, School of Basic Medical Sciences, The Second Affiliated Hospital of Chongqing Medical University, Chongqing Medical University, Chongqing, China.

Journal of orthopaedic translation

|July 15, 2024

概括

这项研究确定了MAPK12和FOS作为关键基因在骨关节炎 (OA) 进展通过调节状细胞衰老. 准这些基因可能为OA提供新的治疗策略.

科学领域:

分子生物学分子生物学
遗传学是一个遗传学.
生物化学生物化学

背景情况:

冠状细胞衰老与骨关节炎 (OA) 的进展有关,但潜在的机制仍然不清楚.
研究OA中与衰老相关的基因生物签名对于了解疾病发展至关重要.

研究的目的:

在OA中识别和分析与冠状细胞衰老相关的基因生物签名.
阐明OA病变发生过程中衰老的机制.

主要方法:

交叉的OA和人类衰老基因数据集,以识别重叠的基因.
在体外和人体OA软骨中验证的枢纽基因 (MAPK12,FOS,CYR61,TNFSF15).
使用各种分子和组织学技术在OA模型中证实了MAPK12和FOS的功能作用.

主要成果:

确定了四个重叠的基因:FOS,CYR61,TNFSF15 (上调) 和MAPK12 (下调).
在OA细胞,人类OA软骨和老鼠软骨中观察到这些基因的改变表达.
证明MAPK12过度表达和FOS倒退抑制衰老,促进软骨健康,并减轻OA模型中的疼痛.

结论:

MAPK12和FOS通过调节状细胞衰老,在OA发育中发挥重要作用.
这些基因代表了OA冠状细胞衰老的潜在生物标志物.
MAPK12和FOS为OA治疗提供了有前途的治疗点.

关键词:

这就是FOSOS.枢纽基因枢纽基因枢纽基因在MAPK12中,您可以使用MAPK12.骨关节炎是一种骨关节炎.衰老是一种衰老.

更多相关视频

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles

Published on: June 2, 2023

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Author Spotlight: Treating Knee Osteoarthritis with Tuina - A New Perspective

Published on: January 12, 2024

相关概念视频

MAPK Signaling Cascades

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...